血小板作为免疫媒介在败血症中的关键作用
Xiaohui Yang1,2, Jiasheng Song1,2, Hui Ma2
1School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, People's Republic of China.
Journal of inflammation research
|September 22, 2025
概括
血小板是败血症的关键参与者,影响免疫力和凝血. 抑制血小板激活为败血症治疗提供了一个有前途的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 关键护理医学 关键护理医学
背景情况:
- 败血症是一种危及生命的疾病,涉及因感染引起的器官功能障碍.
- 血小板计数和功能是败血症严重程度和预后的关键标志物.
- 血小板除了血液静止之外还有其他的作用,它们显著地影响着先天免疫力和败血症的炎症.
研究的目的:
- 系统地审查血小板在败血症发病过程中的多方面的作用.
- 探索血小板作为治疗毒症管理的治疗点.
- 将当前的研究与临床治疗精确性败血症治疗需求相结合.
主要方法:
- 对血小板功能在败血症中的系统文献综述.
- 对病理机制的分析,将血小板与败血症并发症联系起来.
- 评估抗血小板疗法作为潜在的败血症治疗方法.
主要成果:
- 血小板与败血症中不调节的炎症反应和凝血异常有关.
- 血小板激活会加剧与败血症相关的器官功能障碍.
- 抑制血小板激活显示出减轻败血症严重性的潜力.
结论:
- 血小板是败血症的中心媒介,有助于免疫功能障碍和器官损伤.
- 向血小板激活是败血症的可行治疗途径.
- 需要进一步的研究来将这些发现转化为治疗败血症的有效临床干预措施.
相关概念视频
01:18Structure and Function of Platelets
3.0K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
3.0K
01:22Formation of the Platelet Plug
8.8K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.8K
01:05Introduction to Hemostasis
13.4K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
13.4K
01:16Clot Retraction and Fibrinolysis
8.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.5K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.1K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.1K
01:09Coagulation
9.7K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
9.7K